New Zealand neuroscience company Exsurgo announces success of breakthrough chronic pain management trial, UK study paves the way for larger clinical trial due to start soon in New Zealand
A recent UK study has confirmed the exciting potential of a breakthrough treatment for chronic pain management developed by neuroscience company, Exsurgo. Chronic pain (defined as pain that persists for longer than three months) affects up to 1 in 5 people around the world and is a massive burden on healthcare systems and economies. Chronic …